GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » Earnings per Share (Diluted)

Cognetivity Neurosciences (XCNQ:CGN) Earnings per Share (Diluted) : C$-0.10 (TTM As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Earnings per Share (Diluted)?

Cognetivity Neurosciences's Earnings per Share (Diluted) for the three months ended in Oct. 2023 was C$-0.03. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.10.

Cognetivity Neurosciences's EPS (Basic) for the three months ended in Oct. 2023 was C$-0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.10.

Cognetivity Neurosciences's EPS without NRI for the three months ended in Oct. 2023 was C$-0.03. Its EPS without NRI for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.10.

During the past 3 years, the average EPS without NRIGrowth Rate was -9.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was -15.40% per year.

During the past 7 years, Cognetivity Neurosciences's highest 3-Year average EPS without NRI Growth Rate was 5.90% per year. The lowest was -71.00% per year. And the median was -15.60% per year.


Cognetivity Neurosciences Earnings per Share (Diluted) Historical Data

The historical data trend for Cognetivity Neurosciences's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Earnings per Share (Diluted) Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Earnings per Share (Diluted)
Get a 7-Day Free Trial -0.10 -0.06 -0.03 -0.18 -0.08

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.03 -0.02 -0.02 -0.03

Competitive Comparison of Cognetivity Neurosciences's Earnings per Share (Diluted)

For the Health Information Services subindustry, Cognetivity Neurosciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's PE Ratio falls into.



Cognetivity Neurosciences Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Cognetivity Neurosciences's Earnings Per Share (Diluted) for the fiscal year that ended in Jan. 2023 is calculated as

Diluted Earnings Per Share (A: Jan. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-7.434-0)/98.398
=-0.08

Cognetivity Neurosciences's Earnings Per Share (Diluted) for the quarter that ended in Oct. 2023 is calculated as

Diluted Earnings Per Share (Q: Oct. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-2.037-0)/88.369
=-0.02

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Cognetivity Neurosciences  (XCNQ:CGN) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cognetivity Neurosciences Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (XCNQ:CGN) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines